As Figure 7I demonstrates, the percentages of CD11c+ cells, PD-L1+ cells, and CSF1R+ cells were all increased in the whole blood of patients with NSCLC compared with healthy controls. The gene discussed is CSF1R; the disease is non-small cell lung carcinoma.